Literature DB >> 1703358

Measurement of FK 506 by HPLC and isolation and characterization of its metabolites.

U Christians1, C Kruse, R Kownatzki, H M Schiebel, R Schwinzer, M Sattler, R Schottmann, A Linck, V M Almeida, F Braun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1703358

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  18 in total

1.  Interaction between FK506 and clotrimazole in a liver transplant recipient.

Authors:  L Mieles; R Venkataramanan; I Yokoyama; V J Warty; T E Starzl
Journal:  Transplantation       Date:  1991-12       Impact factor: 4.939

2.  Pharmacokinetics of FK 506 in transplant patients.

Authors:  R Venkataramanan; A Jain; V S Warty; K Abu-Elmagd; M Alessiani; J Lever; A Krajak; J Flowers; S Mehta; S Zuckerman
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 3.  In vitro assessment of FK 506 immunosuppressive activity in transplant patients.

Authors:  A Zeevi; R Venkataramanan; V Warty; G Eiras; M Woan; K Abu-Elmagd; M Alessiani; A Jain; A J Demetris; T Zerbe
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 4.  The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Authors:  S M Tsunoda; F T Aweeka
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

5.  Pharmacokinetics of FK506 in liver transplant recipients after continuous intravenous infusion.

Authors:  A B Jain; K Abu-Elmagd; H Abdallah; V Warty; J Fung; S Todo; T E Starzl; R Venkataramanan
Journal:  J Clin Pharmacol       Date:  1993-07       Impact factor: 3.126

6.  Performance of the Dimension TAC assay and comparison of multiple platforms for the measurement of tacrolimus.

Authors:  Eun-Jung Cho; Dae-Hyun Ko; Woochang Lee; Sail Chun; Hae-Kyung Lee; Won-Ki Min
Journal:  J Clin Lab Anal       Date:  2017-11-17       Impact factor: 2.352

7.  Tacrolimus (FK 506) biotransformation in primary rat hepatocytes depends on extracellular matrix geometry.

Authors:  A Bader; E Knop; K H Böker; O Crome; N Frühauf; A K Gonschior; U Christians; H Esselmann; R Pichlmayr; K F Sewing
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-03       Impact factor: 3.000

Review 8.  Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

9.  Protective effect of mycophenolate mofetil against nephrotoxicity and hepatotoxicity induced by tacrolimus in Wistar rats.

Authors:  Hanen Ferjani; Amira El Arem; Aicha Bouraoui; Abedellatif Achour; Salwa Abid; Hassen Bacha; Imen Boussema-Ayed
Journal:  J Physiol Biochem       Date:  2016-01-09       Impact factor: 4.158

Review 10.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.